Results 1 - 8 of 8
More Than Momentum: Stocks Rising for a Reason
Sort a real growth story from a flash in the pan.
7 companies with the urge to merge -- but which deals will work out?
The reasons behind this week's biggest gainers.
Maybe what glitters really is gold.
These companies are buying back their shares. Should you join them?
The specialty pharmaceutical surprisingly renews its share repurchase plan.
More Heartburn From J&J's Natrecor
The company takes a $440 million writedown as the heart drug continues to falter.
5 Health-Care Stocks: Bargain or Bust?
They have strong earnings growth and are well off their 52-week highs. Should you buy?
Results 1 - 8 of 8